BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37985303)

  • 1. Clinical profile of vitiligo patients and relationship with immuno-inflammatory markers.
    Mascarenhas MRM; Oliveira MC; Oliveira LF; Magalhães AS; Machado PRL
    An Bras Dermatol; 2024; 99(2):196-201. PubMed ID: 37985303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo.
    Wang XX; Wang QQ; Wu JQ; Jiang M; Chen L; Zhang CF; Xiang LH
    Br J Dermatol; 2016 Jun; 174(6):1318-26. PubMed ID: 26801009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic CXCL10 is a predictive biomarker of vitiligo lesional skin infiltration, PUVA, NB-UVB and corticosteroid treatment response and outcome.
    El-Domyati M; El-Din WH; Rezk AF; Chervoneva I; Lee JB; Farber M; Uitto J; Igoucheva O; Alexeev V
    Arch Dermatol Res; 2022 Apr; 314(3):275-284. PubMed ID: 33866437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokines in Vitiligo Pathogenesis: CXCL10 and 12.
    Gharib K; Gadallah H; Elsayed A
    J Clin Aesthet Dermatol; 2021 Sep; 14(9):27-32. PubMed ID: 34980968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A similar local immune and oxidative stress phenotype in vitiligo and halo nevus.
    Yang Y; Li S; Zhu G; Zhang Q; Wang G; Gao T; Li C; Wang L; Jian Z
    J Dermatol Sci; 2017 Jul; 87(1):50-59. PubMed ID: 28385330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of chemokines in vitiligo: Recruiting immune cells towards melanocytes.
    Speeckaert R; Belpaire A; Speeckaert MM; van Geel N
    Front Immunol; 2023; 14():1112811. PubMed ID: 36911664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis.
    Ferrari SM; Fallahi P; Santaguida G; Virili C; Ruffilli I; Ragusa F; Centanni M; Antonelli A
    Autoimmun Rev; 2017 Sep; 16(9):946-950. PubMed ID: 28698095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of chemokines and the corresponding receptors in vitiligo: A pilot study.
    Yang L; Yang S; Lei J; Hu W; Chen R; Lin F; Xu AE
    J Dermatol; 2018 Jan; 45(1):31-38. PubMed ID: 29115683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LRP1/CD91 is highly expressed in monocytes from patients with vitiligo - even after repigmentation.
    Piquero-Casals J; Martínez-Martínez L; Alomar A; Rozas-Muñoz E; Juarez C; Puig L
    Exp Dermatol; 2021 Mar; 30(3):390-395. PubMed ID: 33249636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL-10 and Interleukin-6 are reliable serum markers for vitiligo activity: A multicenter cross-sectional study.
    Abdallah M; El-Mofty M; Anbar T; Rasheed H; Esmat S; Al-Tawdy A; Fawzy MM; Abdel-Halim D; Hegazy R; Gawdat H; Bassiouny D; Ibrahim MA; Sany I; El-Bassiouny M; Khalil M; Abdel-Aziz A; El Maadawi ZM; Mostafa WZ;
    Pigment Cell Melanoma Res; 2018 Mar; 31(2):330-336. PubMed ID: 29094481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo.
    Tulic MK; Cavazza E; Cheli Y; Jacquel A; Luci C; Cardot-Leccia N; Hadhiri-Bzioueche H; Abbe P; Gesson M; Sormani L; Regazzetti C; Beranger GE; Lereverend C; Pons C; Khemis A; Ballotti R; Bertolotto C; Rocchi S; Passeron T
    Nat Commun; 2019 May; 10(1):2178. PubMed ID: 31097717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-γ and tumor necrosis factor-α sustain secretion of specific CXC chemokines in human thyrocytes: a first step toward a differentiation between autoimmune and tumor-related inflammation?
    Rotondi M; Coperchini F; Pignatti P; Sideri R; Groppelli G; Leporati P; La Manna L; Magri F; Mariotti S; Chiovato L
    J Clin Endocrinol Metab; 2013 Jan; 98(1):308-13. PubMed ID: 23118425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating active from stable vitiligo: The role of dermoscopic findings and their relation to CXCL10.
    Ibrahim S; Hegazy RA; Gawdat HI; Esmat S; Mahmoud E; Rashed L; Hegazy AA; Saadi DG
    J Cosmet Dermatol; 2022 Oct; 21(10):4651-4658. PubMed ID: 35298096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Inflammatory and Oxidative Stress Markers in Patients with Vitiligo.
    Kassab A; Khalij Y; Ayed Y; Dar-Odeh N; Kokandi AA; Denguezli M; Youssef M
    J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood chemokine profile in untreated early rheumatoid arthritis: CXCL10 as a disease activity marker.
    Pandya JM; Lundell AC; Andersson K; Nordström I; Theander E; Rudin A
    Arthritis Res Ther; 2017 Feb; 19(1):20. PubMed ID: 28148302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo.
    Rashighi M; Agarwal P; Richmond JM; Harris TH; Dresser K; Su MW; Zhou Y; Deng A; Hunter CA; Luster AD; Harris JE
    Sci Transl Med; 2014 Feb; 6(223):223ra23. PubMed ID: 24523323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DCUN1D1, a new molecule involved in depigmentation via upregulating CXCL10.
    Zhao Y; Hu Y; Shen Q; Xiong R; Song X; Guan C
    Exp Dermatol; 2023 Apr; 32(4):457-468. PubMed ID: 36541112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-γ Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome.
    Caldarale F; Giacomelli M; Garrafa E; Tamassia N; Morreale A; Poli P; Timpano S; Baresi G; Zunica F; Cattalini M; Moratto D; Chiarini M; Cannizzo ES; Marchetti G; Cassatella MA; Taddio A; Tommasini A; Badolato R
    Front Immunol; 2021; 12():654587. PubMed ID: 33841438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Circulating CXCL10 in Non-Segmental Vitiligo Concomitant with Autoimmune Thyroid Disease and Alopecia Areata.
    Zhang L; Xu X; Chen S; Kang Y; Wang X; Zhang C; Xiang L
    Ann Dermatol; 2019 Aug; 31(4):393-402. PubMed ID: 33911617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anatomically distinct fibroblast subsets determine skin autoimmune patterns.
    Xu Z; Chen D; Hu Y; Jiang K; Huang H; Du Y; Wu W; Wang J; Sui J; Wang W; Zhang L; Li S; Li C; Yang Y; Chang J; Chen T
    Nature; 2022 Jan; 601(7891):118-124. PubMed ID: 34912121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.